The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a ...

A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights significant ...

Researchers are looking for 200 healthy adults between 65 and 75 who have a close family member with dementia but who do not ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Zahydie Burgos Ribot and her husband Francisco are working on completing their travel bucket list and spending quality time ...

Dementia — the progressive decline in cognitive abilities, impacting memory, language and reasoning — affects more than 6 million Americans and accounts for over 100,000 deaths each year.

People with dementia can get care at home from family or appointed caretakers. Learn how dementia home care helps patients ...